Yuanyuan Wu

Dr. Yuanyuan Wu


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
YWYuan-Yuan Wu
Yuan-Yuan Wu
YWYuanyuan Wu
Yuanyuan Wu
ZLZi-Yu Lu
Zi-Yu Lu
ZTZhuo-Hui Tang
Zhuo-Hui Tang
WLWen-Ting Li
Wen-Ting Li
WMWu Mianhua
Wu Mianhua
Background: The Xiaoai Jiedu recipe (XJR), a traditional Chinese medicinal formula, has been applied clinically for liver cancer management. XJR exhibits promising anti-tumor potential and may offer a novel strategy for oncological intervention. This study was designed to investigate the molecular mechanisms by which XJR exerts its pharmacological effects against hepatocellular carcinoma (HCC). Methods: In vivo assays were conducted employing an HCC xenograft mouse model, and HepG2 cells were employed in vitro . ELISA, immunohistochemistry (IHC), immunofluorescence (IF), RT-PCR and western blot were performed to detect PTEN-induced putative kinase 1 (PINK1)-mediated mitophagy and NLRP3 (NOD-like receptor protein 3) inflammasome activation. The cellular mitochondrial reactive oxygen species (ROS) levels were tested with DCFH-DA and MitoSOX. Transmission electron microscopy (TEM) and JC-1 were utilized to observe the mitochondrial morphology and function, as well as mitochondrial membrane potential (MMP) in the process of XJR intervention for HCC. Results: XJR prominently promoted pyroptosis by upregulating the related inflammatory cytokines levels in serum and HepG2 cells. The key targets include PINK1, parkin, p62, LC3B, TOMM20, COX IV, NLRP3, ASC, GSDMD, caspase1, IL-1β and IL-18 were observed. XJR disrupted PINK1-mediated mitophagy, which in turn increased mitochondrial ROS levels and promoted NLRP3 inflammasome assembly both in vitro and in vivo . Meanwhile, functional assays using pathway-specific inhibitors and siRNA-mediated knockdown further demonstrated that XJR suppresses mitophagy and enhances NLRP3 inflammasome activation via inhibition of the PINK1/parkin signaling pathway. Conclusions: The preliminary results of the present study suggested that XJR may alleviate PINK1-mediated mitophagy and motivate NLRP3 signaling pathway to subsequently exert anti-tumor effects in HCC.